investordatabase.org

Avoro Capital Advisors LLC

avorocapital.com Direct investor

Avoro Capital Advisors is a global life sciences investment firm that invests in public and private biotechnology companies, with a focus on supporting emerging companies and advancing biopharmaceutical innovation.

Avoro Capital Advisors LLC is an asset manager headquartered in New York, United States. It invests directly in companies, from pre-seed to growth, in biotechnology, life sciences and biopharmaceutical.

“Avoro Capital is a global life sciences investment firm with a focus on supporting emerging biotechnology companies.”

— Avoro Capital Advisors LLC, own website
Layer
Direct investor
Type
Asset manager
Stage
Pre-seed – Growth
Headquarters
New York, United States
Invests in
global
Sectors
biotechnology, life sciences, biopharmaceutical

Team, as Avoro Capital Advisors LLC publishes it

  • Behzad Aghazadeh Managing Partner & Portfolio Manager
  • Neil Cammarosano Chief Financial Officer
  • Matthew Canver Director
  • Diane Chien Hedge Fund Controller
  • Mark Chin Investment Partner - Avoro Ventures
  • Uya Chuluunbaatar Investment Partner – Avoro Ventures
  • Scott Epstein Partner, Chief Operating Officer & Chief Compliance Officer
  • Lauren Godlasky Head of Investor Relations & Marketing

Names and roles exactly as listed on avorocapital.com. Nothing else about these people is recorded.

Most shared portfolio companies with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 49 investors with a shared portfolio company. A shared company is not proof they invested together in the same round.

  • RA Capital Management 7 shared companies: ascendispharma.com, hemab.com, vividion.com, bellicum.com…
  • Sofinnova Investments, INC. 7 shared companies: ascendispharma.com, apellis.com, merus.nl, amarincorp.com…
  • Foresite Capital 6 shared companies: ascendispharma.com, adaptimmune.com, bellicum.com, allogene.com…
  • Frazier Life Sciences Management, LP 6 shared companies: acerta-pharma.com, aviditybiosciences.com, scorpiontx.com, amicusrx.com…
  • Atlas Venture 5 shared companies: ethyrealbio.com, intelliatx.com, kymeratx.com, horizontherapeutics.com…
  • Bain Capital Life Sciences 5 shared companies: kymeratx.com, olema.com, amylyx.com, nuvalent.com…
  • Aisling Capital Management LP 4 shared companies: ascendispharma.com, syndax.com, gbt.com, monterosatx.com
  • F-Prime Capital 4 shared companies: apellis.com, adaptimmune.com, aviditybiosciences.com, zogenix.com
  • OrbiMed 4 shared companies: scribetx.com, corvuspharma.com, ottimopharma.com, vanquabio.com
  • EcoR1 Capital 4 shared companies: kuraoncology.com, intelliatx.com, scorpiontx.com, syndax.com

and 39 more — the graph.

Where this comes from

Every fact above was read from a page Avoro Capital Advisors LLC publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 5907 · added 2026-09-03 · link last verified 2026-10-21 · confidence high

Similar investors

Listed under